The seven prospective licensees cover districts ranging from the College Park, Baltimore City and County, as well as Frederick and Washington Counties.
Lori Glauser, company COO and head of the Signal Bay Services division stated "Seven of the eight clients who engaged Signal Bay Services are now proceeding with the final stages of the state licensing process. Only two coveted licenses were available in each district and as many as 25 applications were received in each district and the competition was significant.
Signal Bay anticipates assisting the applicants as they proceed with final licensing and move into the build and operations phase. The company is already working closely with BluPharms, LLC, a dispensary that plans to operate near the University of Maryland.
Ms. Glauser continued "I cannot be more grateful to all of the Signal Bay staff and consultants who made this happen. Top notch professionals, including Dr. Alicia Wilbur, author of Medical Marijuana Desk Reference, and nearly a dozen other experts from across the country, worked around the clock on behalf of our clients during the very short window of application last year."
Will Waldrop, CEO of Signal Bay concluded, "While we have moved swiftly into the cannabis testing space during the past year with our expansion of EVIO Labs from Oregon and into California, we continue to provide consulting services to the industry, which complements the expansion of EVIO Labs. Our consulting services are evolving and expanding from application and startup support to regulatory R&D, product formulation, and operational optimization. While awaiting the results of the Maryland applications, we acquired 4 additional cannabis test labs in Oregon and California, and helped over a dozen Oregon companies attain cultivation, dispensary, and processing licenses. Several of those consulting clients are now testing with EVIO."
About Signal Bay, Inc.: Signal Bay, Inc. is an Oregon-based Life Sciences company. Through its three subsidiaries: EVIO Labs, Signal Bay Research and Signal Bay Services; the Company provides research, consulting services, and analytical testing services to the legal cannabis industry. The Company's EVIO Labs division operates state-of-the-art testing facilities and offers accredited testing methodologies performed by a qualified team of scientists to ensure the safety and quality of the nation's cannabis supply. Learn more at http://SignalBay.com or the company can be reached directly @ 1-888-544-EVIO.
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements may contain certain forward-looking statements pertaining to future anticipated or projected plans, performance and developments, as well as other statements relating to future operations and results. Any statements in this press release that are not statements of historical fact may be considered to be forward-looking statements. Words such as "may," "will," "expect," "believe," "anticipate," "estimate," "intends," "goal," "objective," "seek," "attempt," or variations of these or similar words, identify forward-looking statements. These forward-looking statements by their nature are estimates of future results only and involve substantial risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, our ability to complete our product testing and launch our product commercially, the acceptance of our product in the marketplace, the uncertainty of the laws and regulations relating to cannabis, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed from time to time in our reports filed with the Securities and Exchange Commission, available at www.sec.gov or https://signalbay.com/investors.
SOURCE Signal Bay, Inc.